Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus

Abstract Background and objectives Idiopathic normal pressure hydrocephalus (iNPH) is a progressive but treatable neurological disorder. Yet, diagnosis is often confounded by overlapping symptoms and biomarker profiles with Alzheimer’s disease (AD), mild cognitive impairment (MCI), and frontotempora...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ulrika Hofling, Jenny Jakobsson, Ida Erngren, Oskar Ekman, Eva Freyhult, Akshai Parakkal Sreenivasan, Jakob Siljebo, Sylwia Libard, Lena Kilander, Malin Löwenmark, Martin Ingelsson, Kim Kultima, Johan Virhammar
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2026-02-01
Saila:	Fluids and Barriers of the CNS
Gaiak:	iNPH CSF Metabolomics Biomarkers LC-MS Neurodegeneration
Sarrera elektronikoa:	https://doi.org/10.1186/s12987-026-00771-z
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!